|Year : 2018 | Volume
| Issue : 2 | Page : 143-144
Gossypiboma of Axilla: Imaging Pitfalls on Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography
Manohar Kuruva, Kedar Jambhekar, Sanjaya Viswamitra, Roopa Ram
Department of Radiology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
|Date of Web Publication||15-Mar-2018|
Dr. Manohar Kuruva
Department of Radiology and Nuclear Medicine, University of Arkansas for Medical Sciences, 4301 West Markham Street, Little Rock, Arkansas 72205
Source of Support: None, Conflict of Interest: None
| Abstract|| |
18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) with computed tomography (CT) has become the standard of care in staging, restaging, and response assessment of various malignancies including malignant melanoma. However, nonspecific uptake of FDG can occur in infectious and inflammatory conditions and can mimic a tumor. We present here a case of gossypiboma of the axillary region with FDG uptake detected in a patient with malignant melanoma of the upper extremity and discuss the potential pitfalls of this entity on FDG-PET/CT.
Keywords: 18F-fluorodeoxyglucose positron emission tomography, gossypiboma, melanoma
|How to cite this article:|
Kuruva M, Jambhekar K, Viswamitra S, Ram R. Gossypiboma of Axilla: Imaging Pitfalls on Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography. Indian J Nucl Med 2018;33:143-4
|How to cite this URL:|
Kuruva M, Jambhekar K, Viswamitra S, Ram R. Gossypiboma of Axilla: Imaging Pitfalls on Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography. Indian J Nucl Med [serial online] 2018 [cited 2019 Dec 9];33:143-4. Available from: http://www.ijnm.in/text.asp?2018/33/2/143/227496
| Introduction|| |
18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is one of the most commonly used diagnostic modalities for staging and restaging patients with various malignancies. However, due to its nonspecific nature, FDG uptake can also be seen in nonmalignant conditions such as inflammatory/infectious processes. Certain imaging clues can help in the accurate diagnosis of such nonmalignant causes and avoid pitfalls. We describe a case of gossypiboma of the axilla and highlight the importance of history and correlation with prior imaging in making the diagnosis.
| Case Report|| |
A 57-year-old male patient was diagnosed with malignant melanoma of the right upper arm and treated with wide local excision and sentinel lymph node biopsy. PET/CT performed at the time of surgery did not reveal lymph nodal [Figure 1]a or distant metastatic disease (not shown). Sentinel lymph node biopsy was also negative for metastasis. During the postoperative period, the patient developed wound infection in the right axilla which was successfully treated with debridement and antibiotics. Follow-up FDG-PET/CT scan done after 5 months revealed a new 4.1-cm right axillary mass with moderate FDG uptake (SUVmax= 4.4). Multiple linear radiopaque foci in the surgical bed which were presumed to be surgical clips were seen within the central portion of the mass [Figure 1]b. Due to negative sentinel node biopsy at the time of surgery as well as prior history of postoperative wound infection, the increased FDG uptake was attributed to postoperative granulation tissue and less likely due to the development of metastatic disease and a short-interval follow-up examination was suggested. Follow-up scans performed after 2 months did not show significant interval change. As the patient continued to remain asymptomatic and the lesion showed stability over consecutive scans, no intervention was performed and the biopsy was deferred. The patient was then lost to follow-up.
|Figure 1: (a) Staging positron emission tomography/computed tomography not showing any axillary metastases, (b) Initial follow-up study showing a 18F-fluorodeoxyglucose avid (SUV = 4.4) right axillary mass around radiopaque foreign body, (c) Follow-up positron emission tomography/computed tomography done after 2 years showing intense activity in the right axillary mass (SUV = 14.4) and (d) showing linear wavy hyperdense foreign body in the center of the mass, and (e) X-ray chest revealing a wavy appearance of foreign body suggesting retained surgical sponge|
Click here to view
However, 2 years following the initial surgery, the patient returned with discomfort in the axilla and repeat PET/CT was performed. On repeat FDG-PET/CT, the lesion showed minimal increase in size to 4.6 cm and intense FDG activity with SUVmax of 14.4 [Figure 1]c. On careful review of the images from the CT portion of the PET/CT, suspicion of retained surgical sponge was raised [Figure 1]d. X-rays obtained for confirmation revealed a foreign body with wavy radiopaque hyperdense borders in the right axilla [Figure 1]e-arrow], consistent with the retained surgical sponge. The diagnosis of gossypiboma was strongly considered and surgical resection was performed. Surgical pathology confirmed the presence of retained surgical sponge with foreign body reaction in the surrounding soft tissues, consistent with gossypiboma.
| Discussion|| |
FDG-PET/CT is useful in staging, restaging, and response assessment of patients with malignant melanoma. Due to nonspecific nature of FDG accumulation, FDG uptake can also be seen in various infectious and inflammatory conditions and the knowledge of these entities helps in accurate interpretation. Few earlier case reports have demonstrated foreign body reaction/gossypiboma mimicking tumor in various locations including thorax, neck, and abdomen.,,,, Gossypiboma is defined as foreign body reaction and other inflammatory change which occurs secondary to a retained cotton material/surgical sponge. In our patient, linear hyperdense foci in the axilla were presumed to represent surgical clips, and thus the FDG uptake around them was felt to represent either postsurgical inflammatory changes or recurrent tumor. This is a potential pitfall in imaging as surgical clips are more commonly seen in the region of axilla and can appear similar on axial images. A careful review of CT images revealed the nonmetallic and wavy configuration of the foreign body which raised the suspicion of surgical sponge, which was then confirmed by X-ray. This case demonstrates the usefulness of CT images in interpreting CT and PET/CT images and that accumulation of FDG in postsurgical bed could be not only due to tumor and infection but also due to foreign body reaction around the retained surgical material.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Rohren EM. PET/Computed tomography and patient outcomes in melanoma. PET Clin 2015;10:243-54.
Corrigan AJ, Schleyer PJ, Cook GJ. Pitfalls and artifacts in the use of PET/CT in oncology imaging. Semin Nucl Med 2015;45:481-99.
Mouroux J, Vénissac N, Pop D, Padovani B, Rigo P. 18-FDG PET-scan of intrathoracic gossypiboma during the monitoring of lung cancer. Rev Pneumol Clin 2011;67:154-7.
Rehák Z, Szturz P, Krejčí E, Kocáková I. FDG-PET-positive foreign-body granuloma mimicking residual germinal tumor infiltration. Clin Nucl Med 2012;37:790-2.
Salamon J, Hagel C, Friedrich RE, Mautner VF, Derlin T. Foreign body abscess mimicking a malignant peripheral nerve sheath tumor in a patient with neurofibromatosis type 1. Clin Nucl Med 2015;40:674-5.
Sugiura Y, Kawamura M, Nemoto E, Kaseda S. Foreign body granuloma with positive 18-fluorodeoxyglucose positoron emission tomography(FDGPET) 3 years after thymectomy. Kyobu Geka 2013;66:387-90.
Yuh-Feng T, Chin-Chu W, Cheng-Tau S, Min-Tsung T. FDG PET CT features of an intraabdominal gossypiboma. Clin Nucl Med 2005;30:561-3.